RV

Reena Verma

Director Director DIN 01808255
DIN 01808255 First appointment Dec 2005 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2005
Shareholding value •••• Premium profile

About Reena Verma

Data last updated:

Reena Verma was a Director at R Kure Pharmaceuticals Private Limited (2005–2008) and Director at Biogenix Medicals India Private Limited (2008–2009). The companies operate in Chemicals and Trading.

DIN 01808255
Primary Designation Director
Industry Chemicals
First Appointment 01 Dec 2005

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20052005Strike Off
Director30 Jan 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
R Kure Pharmaceuticals Private Limited
Biogenix Medicals India Private Limited
Premium access

Shareholding and investment profile for Reena Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Verma

Reena Verma was first appointed on 01 Dec 2005 as Director at R Kure Pharmaceuticals Private Limited. The most recent appointment on record is 30 Jan 2008 at Biogenix Medicals India Private Limited.

Reena Verma held 2 earlier board appointments: R Kure Pharmaceuticals Private Limited (Director, 01 Dec 2005 to 01 Feb 2008); Biogenix Medicals India Private Limited (Director, 30 Jan 2008 to 12 Feb 2009).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available